Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 118 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,859 | -54.8% | 8,231 | -43.7% | 0.00% | – |
Q2 2023 | $99,256 | +180.3% | 14,618 | +106.8% | 0.00% | – |
Q1 2023 | $35,416 | +96.8% | 7,069 | +447.6% | 0.00% | – |
Q3 2022 | $18,000 | -21.7% | 1,291 | -15.8% | 0.00% | – |
Q2 2022 | $23,000 | -89.2% | 1,533 | -91.4% | 0.00% | – |
Q1 2022 | $212,000 | -54.9% | 17,887 | -38.2% | 0.00% | – |
Q4 2021 | $470,000 | -60.9% | 28,965 | -31.2% | 0.00% | – |
Q3 2021 | $1,203,000 | +114.1% | 42,123 | +153.8% | 0.00% | – |
Q2 2021 | $562,000 | +29.2% | 16,600 | +15.5% | 0.00% | – |
Q1 2021 | $435,000 | -67.3% | 14,374 | -46.5% | 0.00% | – |
Q4 2020 | $1,331,000 | +110.6% | 26,885 | +63.7% | 0.00% | – |
Q3 2020 | $632,000 | -20.1% | 16,424 | -10.3% | 0.00% | – |
Q2 2020 | $791,000 | +140.4% | 18,308 | +45.4% | 0.00% | – |
Q1 2020 | $329,000 | -4.1% | 12,588 | +14.6% | 0.00% | – |
Q4 2019 | $343,000 | -50.6% | 10,982 | -58.8% | 0.00% | – |
Q3 2019 | $695,000 | +58.7% | 26,672 | +38.9% | 0.00% | – |
Q2 2019 | $438,000 | +356.2% | 19,203 | +422.2% | 0.00% | – |
Q1 2019 | $96,000 | +37.1% | 3,677 | +2.1% | 0.00% | – |
Q4 2018 | $70,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |